Survival rate and prognostic factors in advanced cervical cancer patients accompanied by renal impairment

被引：0

作者：

Rasjidi, Imam ^{[1
,2
]}

Nuranna, Laila ^{[2
,3
]}

Aziz, M. Farid ^{[2
,3
]}

Andrijono, Andrijono ^{[2
,3
]}

Purbadi, Sigit ^{[2
,3
]}

Rochani, Rochani ^{[2
,4
]}

Supriana, Nana ^{[2
,5
]}

Dharmeizar, Dharmeizar ^{[2
,6
]}

Sutrisna, Bambang ^{[7
]}

机构：

[1] Univ Indonesia, Fac Med, Dept Obstet & Gynecol, Depok, Indonesia

[2] Dr Cipto Mangunkusumo Hosp, Jakarta, Indonesia

[3] Univ Indonesia, Fac Med, Dept Obstet & Gynecol, Div Oncol, Depok, Indonesia

[4] Univ Indonesia, Fac Med, Dept Urol, Depok, Indonesia

[5] Univ Indonesia, Fac Med, Dept Radiotherapy, Depok, Indonesia

[6] Univ Indonesia, Fac Med, Dept Internal Med, Depok, Indonesia

[7] Univ Indonesia, Fac Publ Hlth, Dept Epidemiol, Depok, Indonesia

来源：

MEDICAL JOURNAL OF INDONESIA | 2005年 / 14卷 / 03期

关键词：

Advanced cervical cancer; renal impairment; nephrostomy; survival; prognostic factor; scoring system;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The objective of this study was to obtain information on the survival rate of advanced cervical cancer patients with renal impairment (ACCRI) and its prognostic factors. In addition, it is hoped that by this method the scoring system for predicting the death of ACCRI patients hopetully could be obtained. Design of the study used was retrospective cohort study. Data collected were retrieved from medical records of ACCRI patients from 1 January 1998 to 31 December 2003 at Dr. Cipto Mangunkusumo National Central General Hospital, Jakarta, with a total sample of 70 cases. The results of the study showed that mean survival of all ACCRI patients was 8.2 months, mean survival at sixth month was 39%, and mean survival at one year was 3.2%. Median survival was 5.3 months. Prognostic factors affecting the survival of ACCRI patients included histopathological type (adenosquamous cell and cell differentiation), cortical thickness of the kidney less than 1 cm, and nephrostomy.

引用

页码：173 / 178

页数：6

共 11 条

[1]

Ahmed Iftikhar, 1995, JPMA (Journal of the Pakistan Medical Association), V45, P16

[2]

Aziz MF, 1998, SUBUNITS ONCOLOGY GY, P37

[3] Percutaneous nephrostomy in malignant ureteric obstruction [J].

Demetriou, D ;

Sebeikat, D .

DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1996, 121 (49) :1526-1530

[4] PALLIATIVE PERCUTANEOUS AND ENDOSCOPIC URINARY-DIVERSION FOR MALIGNANT URETERAL OBSTRUCTION [J].

GASPARINI, M ;

CARROLL, P ;

STOLLER, M .

UROLOGY, 1991, 38 (05) :408-412

[5] PALLIATION OF OBSTRUCTIVE NEPHROPATHY DUE TO MALIGNANCY [J].

HARRINGTON, KJ ;

PANDHA, HS ;

KELLY, SA ;

LAMBERT, HE ;

JACKSON, JE ;

WAXMAN, J .

BRITISH JOURNAL OF UROLOGY, 1995, 76 (01) :101-107

[6]

HOPKINS MP, 1993, CANCER-AM CANCER SOC, V72, P2389, DOI 10.1002/1097-0142(19931015)72:8<2389::AID-CNCR2820720816>3.0.CO

[7]

2-R

[8]

Nuranna L, 1995, MANAGEMENT ADV CERVI

[9]

Roesma Jose, 1990, PEMERIKSAAN PENUNJAN

[10]

Saroyo YB, 2000, MAJ OBSTET GINEKOL I, V24, P109

← 1 2 →